All In Biotech

Free tool

FAERS Monitor: Sprycel

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021986 or its brand name (Sprycel, Dasatinib). Reports on generic versions are filed under their own applications.

Reports

37,260

Serious

22,458

60% of reports

Hospitalization

8,860

Death reported

3,748

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pleural effusion3,282
  • fatigue2,554
  • diarrhoea2,178
  • nausea2,151
  • death2,131
  • headache2,014
  • rash1,618
  • drug ineffective1,554
  • dyspnoea1,513
  • adverse event1,478
  • off label use1,321
  • hospitalisation1,223
  • pulmonary oedema1,016
  • vomiting961
  • pyrexia898

Reports by year received

View as table
YearReports
200694
2007313
2008417
2009406
2010519
2011522
20121,181
20131,281
20142,403
20152,571
20162,506
20172,408
20182,703
20193,279
20202,830
20212,942
20222,643
20232,739
20242,897
20251,632
2026974

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,899 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pleural effusionSignal3,28232.131.193,864
pulmonary oedemaSignal1,01613.112.311,094
adverse eventSignal1,4789.28.710,645
hospitalisationSignal1,2234.54.33,348
rashSignal1,6182.12.0947
diarrhoea2,1781.91.8966
fatigue2,5541.91.81,040
headache2,0141.81.7758
nausea2,1511.51.5416
dyspnoea1,5131.51.4267
pyrexia8981.51.4135
death2,1311.41.3250
vomiting9611.21.120
off label use1,3210.90.836
drug ineffective1,5540.70.6279

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.